ENTITY

Chimeric Therapeutics (CHM AU)

8
Analysis
Health Care • Australia
Chimeric Therapeutics Limited operates as a biotechnology company. The Company develops CAR T cell therapies for solid tumors based on research at the City of Hope Cancer Centre in Los Angeles. Chimeric Therapeutics serves customers worldwide.
more
bullish•Chimeric Therapeutics
•09 Sep 2022 08:00•Issuer-paid

Chimeric Therapeutics Limited - Assembling a World-Class Team, Partners and Assets

Chimeric Therapeutics Limited Assembling a world-class team, partners and assets Chimeric Therapeutics Limited (ASX:CHM) is a...

Share
bullish•Chimeric Therapeutics
•03 Mar 2022 08:00•Issuer-paid

Chimeric Therapeutics Ltd - Entitlement Offer to Raise up to $18.1M

Chimeric Therapeutics Ltd Entitlement offer to raise up to $18.1M Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company...

Share
bullish•Chimeric Therapeutics
•09 Feb 2022 08:00•Issuer-paid

Chimeric Therapeutics Ltd: Hitting Milestones and Pipeline Flowing

Chimeric Therapeutics Ltd Hitting milestones and pipeline flowing Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell therapy company...

Share
bullish•Chimeric Therapeutics
•17 Dec 2021 08:00•Issuer-paid

Chimeric Therapeutics Ltd: Adding to the Pipeline with a Clinical Platform Technology

Chimeric Therapeutics Ltd Adding to the pipeline with a clinical platform technology Chimeric Therapeutics (ASX:CHM) is a clinical-stage cell...

Share
bullish•Chimeric Therapeutics
•06 Dec 2021 16:20•Issuer-paid

Chimeric Therapeutics - Acquiring an exciting new NK cell technology

Chimeric has announced that it has entered into an exclusive option agreement to license the clinically validated, off the shelf, robust, enhanced...

Share
No more insights
x